|
nasdaq:nktr
|
165136
|
Apr 14th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
578.00
|
Open
|
|
Apr 13th, 2024 11:26PM
|
Apr 13th, 2024 11:26PM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 13th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
579.00
|
Open
|
|
Apr 12th, 2024 11:18PM
|
Apr 13th, 2024 11:51AM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 12th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
579.00
|
Open
|
|
Apr 11th, 2024 11:23PM
|
Apr 12th, 2024 08:47AM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 11th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
580.00
|
Open
|
|
Apr 10th, 2024 11:56PM
|
Apr 11th, 2024 11:32AM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 10th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
580.00
|
Open
|
|
Apr 9th, 2024 11:25PM
|
Apr 10th, 2024 05:40PM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 9th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
580.00
|
Open
|
|
Apr 8th, 2024 11:36PM
|
Apr 9th, 2024 10:21AM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 8th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
580.00
|
Open
|
|
Apr 8th, 2024 12:01AM
|
Apr 8th, 2024 07:19PM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 7th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
581.00
|
Open
|
|
Apr 6th, 2024 11:31PM
|
Apr 6th, 2024 11:31PM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 6th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
580.00
|
Open
|
|
Apr 5th, 2024 11:32PM
|
Apr 5th, 2024 11:32PM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:nktr
|
165136
|
Apr 5th, 2024 12:00AM
|
Nektar Therapeutics
|
26K
|
580.00
|
Open
|
|
Apr 4th, 2024 11:59PM
|
Apr 4th, 2024 11:59PM
|
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and viral diseases. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
|
Open
|
Drug Development and Polymer Conjugate Chemistry
|
Open
|
455 Mission Bay Boulevard South
|
San Francisco
|
California
|
US
|
94158
|
|
Nektar Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|